MarginsXMarginsX
Home › Markets › Health Care › NTRA

Natera Inc. (NTRA)

NTRA trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$288.48
-9.59% on the day
Market cap
$41.8B
Large cap
Revenue · 2025
$2.3B
+35.9% on 2024
Net income · 2025
-$208.2M
-9.0% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1604821/000110465926020881/0001104659-26-020881-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerNTRA on Nasdaq
SectorHealth Care
IndustryMedical Specialities
CountryUnited States
IPO year2015
SEC CIK0001604821
SEC industry codeServices-Medical Laboratories
Incorporated inDE

Financials · 2025

LineValue
Revenue$2.3B
Net income-$208.2M
Operating income-$309.9M
Net margin-9.0%
Operating margin-13.4%
Revenue growth+35.9%
Cash$1.1B
Total assets$2.4B
P/E (computed)Net income was not positive
P/S (computed)18.1×

Warning signs

Cash runway
Cash-flow positive
$1.1B cash at September 30, 2026
Share count, 1 year
+5.1%
2025-10-31 to 2026-10-31 · +20.7% over 3 years
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
-$379.8M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$1.1B cash; operating cash flow $53.2M a quarter.Report 2026-09-30
Shares outstanding145,004,521 (2026-10-31); 138,014,465 a year earlier; 120,151,688 three years earlier.Cover page 2026-10-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months3 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-11-12
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, San Jose, California, United StatesPCAOB Form AP 2026-03-18
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $379.8M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$794.0M-$59.9M$43.9M$1.1B$80.3M$2.9B10-Q 2026-11-05
Q2 2026
2026-06-30
$752.8M-$67.0M$54.8M$1.1B$80.3M$2.7B10-Q 2026-08-07
Q1 2026
2026-03-31
$696.6M-$85.1M$40.2M$1.1B$80.3M$2.5B10-Q 2026-05-08
Q4 2025
2025-12-31
$665.5M$47.3M$73.9M$1.1B$80.3M$2.3B10-K 2026-02-27
Q3 2025
2025-09-30
$592.2M-$87.5M$59.4M$1.0B$80.3M$2.1B10-Q 2026-11-05
Q2 2025
2025-06-30
$546.6M-$100.9M$37.6M$1.0B$80.3M$2.0B10-Q 2026-08-07
Q1 2025
2025-03-31
$501.8M-$66.9M$44.5M$973.8M$80.3M$1.8B10-Q 2026-05-08
Q4 2024
2024-12-31
$476.1M-$53.8M$52.9M$945.6M$80.4M$1.7B10-K 2026-02-27

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2026-11-12
Latest annual report10-K2026-02-27
Latest quarterly / interim10-Q2026-11-05
Latest current report8-K2026-11-05
Latest proxyDEFA14A2026-04-23

Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+2.7%
1 month-19.4%
3 months+2.7%
Year to date+39.3%
1 year+59.0%
From 52-week high-26.8%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical Specialities

TickerCompanyPriceDayMarket cap
CNCCentene Corporation$74.77+4.91%$37.0B
HUMHumana Inc.$461.25+2.50%$55.4B
LHLabcorp Holdings Inc.$372.46+0.53%$30.2B
ILMNIllumina Inc.$198.00-4.35%$29.9B
DGXQuest Diagnostics Incorporated$262.21+1.01%$28.8B
CIThe Cigna Group$300.16+1.06%$79.1B
GHGuardant Health Inc.$144.03-5.06%$19.5B
ELVElevance Health Inc.$446.28+3.86%$96.4B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier